Genetic and Epigenetic Changes at Secondary Resistance after Continued Treatment in the Randomized Phase II Study of All-Trans Retinoic Acid (ATRA) and/or Valproic Acid (VPA) Added to Decitabine (DAC) in Newly Diagnosed Elderly AML Patients (DECIDER Trial)

Saved in:
Bibliographic Details
Published in:Blood 2022-11, Vol.140 (Supplement 1), p.3383-3384
Main Authors: Hund, Inga, Hess, Maria, Stomper, Julia, Greve, Gabriele, Mitschke, Jan, Niemöller, Christoph, Ma, Tobias, Uhl, David, Thol, Felicitas R., Heuser, Michael, Bug, Gesine, Crysandt, Martina, Mueller, Lutz Peter, Neubauer, Andreas, Duyster, Justus, Dohner, Hartmut, Boerries, Melanie, Becker, Heiko, Luebbert, Michael
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2022-163220